Article

Helen Keller International wins award for its role in onchocerciasis

A winner has been announced for the latest Arab Gulf Programme for United Nations Development Organization prize. The blindness charity Helen Keller International (HKI) has won for its role in onchocerciasis (river blindness) control in 10 African countries.

Riyadh, Saudi Arabia and New York City-A winner has been announced for the latest Arab Gulf Programme for United Nations Development Organization prize. The blindness charity Helen Keller International (HKI) has won for its role in onchocerciasis (river blindness) control in 10 African countries.

The project was nominated by the United Nations Children's Fund and a judges’ committee composed of professional experts chose it from five nominated projects.

HKI aims to reach 102 million people at risk of onchocerciasis in Burkina Faso, Côte d’Ivoire, Cameroon, Democratic Republic of Congo, Guinea, Mali, Niger, Nigeria, Sierra Leone, and Tanzania.

Founded in 1915, HKI is among the oldest international non-profit organizations devoted to fighting and treating preventable blindness and malnutrition.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.